<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Hormonal Contraceptives: Injectables and Implants</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css"> <!-- Include MathJax -->
    <script>    
    MathJax = { tex: { inlineMath: [['$', '$'], ['\(', '\)']], displayMath: [['$$', '$$'], ['\[', '\]']], processEscapes: true, processEnvironments: true, tags: 'ams' // Use AMS numbering of equations        },        svg: { fontCache: 'global' },        options: {            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']        }    };    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>

<body>
    <div class="container">
        <article class="document-section" role="main"> <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links"> <a href="../index.html" class="nav-button"> <span class="nav-icon"></span> <span
                            class="nav-text">Table of Contents</span> </a> <a
                        href="04-hormonal-contraceptives-part-1.html" class="nav-button"> <span
                            class="nav-icon">←</span> <span class="nav-text">Previous Section</span> </a>
                    <div class="document-progress">
                        <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 71.4%;"></div>
                        </div> <span class="progress-text">Lecture 5 of 7</span>
                    </div> <a href="06-iucds-and-barrier-methods.html" class="nav-button"> <span class="nav-text">Next
                            Section</span> <span class="nav-icon">→</span> </a>
                </div>
            </nav>  <header class="section-header">
                <h1 class="section-title">Hormonal Contraceptives (Continued)</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                <!-- START: injectables -->
                <section id="injectables" class="content-section" aria-labelledby="section-heading-injectables">
                    <h2 id="section-heading-injectables" class="section-heading">
                        <span class="heading-icon"> </span>
                        <span class="heading-text">INJECTABLE CONTRACEPTIVES</span>
                    </h2>
                    <div class="content-card">
                        <p>Injectable contraceptives contain one or two contraceptive hormones and provide protection
                            from pregnancy for one, two, or three months (depending on the type) following an injection.
                            The most widely used injectable methods contain only a progestin (Progestin only Injectable
                            Contraceptives or POIC). Less common methods are those that contain both progestin and
                            oestrogen (Combined Injectable Contraceptives or CIC).</p>

                        <h3 class="subsection-heading">ADVANTAGES OF INJECTABLE CONTRACEPTIVES</h3>
                        <h4 class="subsubsection-heading">Contraceptive Benefits</h4>
                        <ul>
                            <li>They are highly effective and safe.</li>
                            <li>A pelvic exam is not required to initiate use.</li>
                            <li>They contain no oestrogen, so they do not have the cardiac and blood-clotting effects,
                                which are associated with oestrogen-containing pills and injectables.</li>
                            <li>These are long-acting methods: each injection provides protection for two or three
                                months, depending on the type.</li>
                            <li>Confidentiality highly maintained</li>
                        </ul>

                        <h4 class="subsubsection-heading">Non-contraceptive Health Benefits</h4>
                        <ul>
                            <li>Amenorrhea, which might be beneficial for women with (or at risk of) iron-deficiency
                                anaemia</li>
                            <li>Decrease in sickle cell crises</li>
                            <li>Reduction of symptoms of endometriosis</li>
                            <li>Protection against endometrial cancer</li>
                            <li>Protection against uterine fibroids</li>
                            <li>Possible protection from symptomatic pelvic inflammatory disease</li>
                            <li>Possible prevention of ectopic pregnancy</li>
                        </ul>

                        <h3 class="subsection-heading">LIMITATIONS OF INJECTABLE CONTRACEPTIVES</h3>
                        <p>The limitations associated with Injectable contraceptives include:</p>
                        <ul>
                            <li>Return of fertility may be delayed for about four months or longer after
                                discontinuation.</li>
                            <li>They offer no protection against STIs, including hepatitis B and HIV; individuals at
                                risk for these should use condoms in addition to injectable contraceptives.</li>
                            <li>This method is provider-based, so a woman must go to a health care facility regularly
                            </li>
                        </ul>

                        <h3 class="subsection-heading">SIDE EFFECTS</h3>
                        <ul>
                            <li>Menstrual changes, such as:
                                <ul>
                                    <li>irregular bleeding</li>
                                    <li>heavy and prolonged bleeding</li>
                                    <li>light spotting or bleeding</li>
                                    <li>amenorrhea, especially after one year of use</li>
                                </ul>
                            </li>
                            <li>Weight gain</li>
                            <li>Headache</li>
                            <li>Dizziness</li>
                            <li>Mood swings</li>
                            <li>Abdominal bloating</li>
                            <li>Decrease in sex drive</li>
                        </ul>

                        <h3 class="subsection-heading">When to Start</h3>
                        <ul>
                            <li>A woman can start injectables at any time if it is reasonably certain she is not
                                pregnant.</li>
                            <li>If she starts using an injectable within seven days after the start of her monthly
                                bleeding, she will not need a back-up method.</li>
                            <li>If she starts using an injectable more than seven days after her monthly bleeding, she
                                should use a backup method for the first seven days after injection.</li>
                        </ul>

                        <h3 class="subsection-heading">Giving the Injection</h3>
                        <p>Providers should follow these guidelines for giving injectable contraceptives:</p>
                        <ul>
                            <li>Use disposable syringes and needles.</li>
                            <li>Do not reuse disposable syringes and needles.</li>
                            <li>Observe proper handling and disposal of needles and syringes</li>
                            <li>Do not massage the injection site, and instruct the client not to massage or rub the
                                site, as this could cause DMPA to be absorbed too fast.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: injectables -->

                <!-- START: implants -->
                <section id="implants" class="content-section" aria-labelledby="section-heading-implants">
                    <h2 id="section-heading-implants" class="section-heading">
                        <span class="heading-icon"> </span>
                        <span class="heading-text">CONTRACEPTIVE IMPLANTS</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Description</h3>
                        <p>Contraceptive implants are small rods that are inserted under the skin of a woman's upper arm
                            to release the hormone progestin slowly and prevent pregnancy. Contraceptive implants, which
                            are also called sub-dermal implants, do not contain oestrogen; therefore, they are free from
                            the side effects associated with that hormone. The latest implant to be registered in Kenya
                            is the two-rod Sino-implant-II (Zarin). Contraceptive implants prevent pregnancy primarily
                            by making cervical mucus too thick for sperm to pass through it, and they also suppress
                            ovulation in many cycles.</p>

                        <div class="table-container">
                            <table class="content-table">
                                <caption>TYPES OF CONTRACEPTIVE IMPLANTS</caption>
                                <thead>
                                    <tr>
                                        <th>Device</th>
                                        <th>Design</th>
                                        <th>Hormone</th>
                                        <th>Duration of effectiveness</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>Jadelle</td>
                                        <td>2 rods</td>
                                        <td>Levonorgestrel 75 mg/rod</td>
                                        <td>5 years</td>
                                    </tr>
                                    <tr>
                                        <td>Implanon</td>
                                        <td>1 rod</td>
                                        <td>Etonogestrel 68 mg/rod</td>
                                        <td>3 years</td>
                                    </tr>
                                    <tr>
                                        <td>Sino-implant [ZARIN] 75 mg/rod</td>
                                        <td>2 Rods</td>
                                        <td>Levonorgestrel</td>
                                        <td>4 years(possibly 5)</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>

                        <h3 class="subsection-heading">INDICATIONS</h3>
                        <p>The following categories of women can use implants:</p>
                        <ul>
                            <li>Women of reproductive age</li>
                            <li>Women of any parity, nulliparous included</li>
                            <li>Breast feeding mothers after six weeks post partum</li>
                            <li>Heavy smokers of any age</li>
                            <li>Women who can not use combined oral pills due to oestrogen related contraindications
                            </li>
                            <li>Post abortion patients</li>
                            <li>Women with sickle cell disease, hypertension or valvular heart disease</li>
                        </ul>

                        <h3 class="subsection-heading">CONTRAINDICATIONS</h3>
                        <ul>
                            <li>Breast feeding mothers less than six weeks post natal</li>
                            <li>Pregnant or suspected to be pregnant</li>
                            <li>Women with unexplained abnormal vaginal bleeding</li>
                            <li>Women who have breast cancer or history of breast cancer</li>
                            <li>Women with active liver disease</li>
                        </ul>

                        <h3 class="subsection-heading">Contraceptive Benefits of implants</h3>
                        <ul>
                            <li>Contraception is immediate if inserted within the first seven days of menstrual cycle,
                                or within the first five days for Implanon.</li>
                            <li>There is no delay in return to fertility.</li>
                            <li>They offer continuous, long-term protection</li>
                        </ul>

                        <h3 class="subsection-heading">Non-contraceptive Health Benefits</h3>
                        <ul>
                            <li>Implants do not affect breastfeeding.</li>
                            <li>They reduce menstrual flow.</li>
                            <li>They help prevent ectopic pregnancy (but do not eliminate the risk altogether).</li>
                            <li>They protect against iron-deficiency anaemia.</li>
                            <li>They help protect from symptomatic PID.</li>
                        </ul>

                        <h3 class="subsection-heading">Limitations & side effects of contraceptive implants</h3>
                        <ul>
                            <li>Contraceptive implants must be inserted and removed by trained providers. This requires
                                a minor surgical procedure with appropriate infection prevention practices.</li>
                            <li>Common side effects of using implants include menstrual changes, such as irregular light
                                spotting or bleeding, prolonged bleeding, infrequent bleeding, and amenorrhea.</li>
                            <li>Non-menstrual side effects include headache, dizziness, nausea, breast tenderness, mood
                                changes, weight change, and mild abdominal pain.</li>
                            <li>Contraceptive implants do not protect against STIs including hepatitis B and HIV.
                                Individuals at risk should use condoms in addition to the implants.</li>
                        </ul>

                        <h3 class="subsection-heading">Timing for implant insertion</h3>
                        <p><strong>If the woman is having her menstrual cycles;</strong></p>
                        <ul>
                            <li>Insert implant within 7 days after the start of her menstrual bleeding (within the first
                                5 days for Implanon). No additional contraceptive protection is needed.</li>
                            <li>Insert implant any other time if it is reasonably certain that she is not pregnant. If
                                it has been more than 7 days since menstrual bleeding started (within the first 5 days
                                for Implanon), she will need additional contraceptive protection for the next 7 days
                                (e.g., condoms, FAM, or Coitus Interruptus).</li>
                        </ul>
                        <p><strong>If the woman is amenorrhoeic.</strong></p>
                        <ul>
                            <li>Insert implant any time if it is reasonably certain that she is not pregnant. She will
                                need additional contraceptive protection for the next 7 days.</li>
                        </ul>

                        <h3 class="subsection-heading">Instructions to Women</h3>
                        <h4 class="subsubsection-heading">After Insertion:</h4>
                        <p>Counsel women to expect some soreness or bruising (or both), after anesthetic wears off. This
                            is common and does not require treatment. Instruct the client on the following;</p>
                        <ul>
                            <li>Keep insertion area dry for four to five days.</li>
                            <li>Remove the gauze bandage after one or two days, but leave the adhesive plaster in place
                                for an additional five days.</li>
                            <li>Return to the clinic if the rods come out or if soreness develops after the removal of
                                the adhesive plaster.</li>
                            <li>Return to the clinic if she experiences pain, heat, pus, or redness at the insertion
                                site, or if she sees a rod come out.</li>
                        </ul>

                        <h4 class="subsubsection-heading">Instructions for Clients Following Removal of Implants</h4>
                        <p>Instruct on the foll:</p>
                        <ul>
                            <li>Keep removal area dry for four to five days.</li>
                            <li>Remove the gauze bandage after one or two days, but leave the adhesive plaster in place
                                for an additional five days.</li>
                            <li>Return to the clinic if swelling and pain develops after the removal of the adhesive
                                plaster.</li>
                        </ul>

                        <h3 class="subsection-heading">SIDE EFFECTS</h3>
                        <ul>
                            <li>Amenorrhoea</li>
                            <li>Irregular spotting or light bleeding</li>
                            <li>Heavy or prolonged bleeding (more than eight days or twice as much as her usual
                                menstrual period)</li>
                            <li>Recurrent and persistent headaches especially with blurred vision</li>
                            <li>Implant expulsion</li>
                        </ul>

                        <h3 class="subsection-heading">Treatment for Light or Heavy Bleeding</h3>
                        <h4 class="subsubsection-heading">Treatment with NSAIDs</h4>
                        <ul>
                            <li>Ibuprofen: 800 mg three times a day for five days</li>
                            <li>Mefenamic acid: 500 mg twice a day for five days</li>
                        </ul>
                        <h4 class="subsubsection-heading">Hormonal management</h4>
                        <ul>
                            <li>Low-dose COCs: 30 &mu;g ethinylestradiol 150 &mu;g levonorgestrel a day for 21 days</li>
                            <li>COCs: 50 &mu;g ethinylestradiol 250 &mu;g levonorgestrel a day for 21 days</li>
                            <li>Ethinylestradiol: 50 &mu;g a day for 20 days</li>
                        </ul>
                        <h4 class="subsubsection-heading">Heamostatics:</h4>
                        <p>Transnexamic acid 500 mg three times a day for five days or Sylate 500 mg three times a day
                            for five days</p>
                    </div>
                </section>
                <!-- END: implants -->
            </main>

            <!-- Bottom Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="04-hormonal-contraceptives-part-1.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                        <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 71.4%;"></div>
                        </div>
                        <span class="progress-text">Lecture 5 of 7</span>
                    </div>
                    <a href="06-iucds-and-barrier-methods.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>
        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>

</html>